Related references
Note: Only part of the references are listed.Long-term Use of Antibiotics and Proton Pump Inhibitors Predict Development of Infections in Patients With Cirrhosis
Jacqueline G. O'Leary et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health?
Silvia Melgar et al.
GASTROENTEROLOGY (2015)
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Jasmohan S. Bajaj et al.
HEPATOLOGY (2015)
Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality
Yanfei Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Decompensated cirrhosis and microbiome interpretation
Jasmohan S. Bajaj et al.
NATURE (2015)
Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?
Debbie L. Shawcross
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against β-lactam antibiotics
Regis Stentz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial
Radha K. Dhiman et al.
GASTROENTEROLOGY (2014)
Diabetes Mellitus Is an Independent Prognostic Factor for Major Liver-Related Outcomes in Patients With Cirrhosis and Chronic Hepatitis C
Laure Elkrief et al.
HEPATOLOGY (2014)
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
Gut microbiota and metabolic syndrome
Davide Festi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
An Automated Model Using Electronic Medical Record Data Identifies Patients With Cirrhosis at High Risk for Readmission
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Genta Kakiyama et al.
JOURNAL OF HEPATOLOGY (2013)
Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
Jasmohan S. Bajaj et al.
PLOS ONE (2013)
Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Xiuying Zhang et al.
PLOS ONE (2013)
Commentary: PPIs and risk of serious infection in decompensated cirrhosis - authors' reply
J. S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Hospital Readmissions Among Patients With Decompensated Cirrhosis
Michael L. Volk et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Second Infections Independently Increase Mortality in Hospitalized Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease (NACSELD) Experience
Jasmohan S. Bajaj et al.
HEPATOLOGY (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
Incidence and Predictors of 30-Day Readmission Among Patients Hospitalized for Advanced Liver Disease
Kenneth Berman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis
Yanfei Chen et al.
HEPATOLOGY (2011)
Metagenomic biomarker discovery and explanation
Nicola Segata et al.
GENOME BIOLOGY (2011)
Quantitative Assessment of the Human Gut Microbiome Using Multitag Pyrosequencing
Patrick Gillevet et al.
CHEMISTRY & BIODIVERSITY (2010)
High prevalence of diabetes mellitus in patients with liver cirrhosis
N. Wlazlo et al.
DIABETIC MEDICINE (2010)
Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2) Variants Are Genetic Risk Factors for Death and Spontaneous Bacterial Peritonitis in Liver Cirrhosis
Beate Appenrodt et al.
HEPATOLOGY (2010)
Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of Nosocomial Clostridum difficile-Associated Disease
Amee R. Manges et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
The role of the gut microbiota in nonalcoholic fatty liver disease
Ahmed Abu-Shanab et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo
Barjesh Chander Sharma et al.
GASTROENTEROLOGY (2009)
Microbial community profiling for human microbiome projects: Tools, techniques, and challenges
Micah Hamady et al.
GENOME RESEARCH (2009)
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
James Robert White et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Microbial ecology - Human gut microbes associated with obesity
Ruth E. Ley et al.
NATURE (2006)
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
M Malinchoc et al.
HEPATOLOGY (2000)
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease
NN Zein et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
